The EMS Group, active worldwide in the business areas High Performance Polymers and Specialty Chemicals, and with its companies combined in the EMS-CHEMIE HOLDING AG, informs as follows:
The financial services provider Kepler Cheuvreux S.A. adjusted its target price for EMS shares in its equity research report dated November 4, 2025, due to changes in assumptions in their valuation model (WACC, P/E).
The EMS Group emphasizes that the assessments and expectations published in the Third-Quarter Report dated October 16, 2025 remain unchanged. For the business year 2025, EMS continues to expect net operating income (EBIT) slightly above previous year.
